These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9270695)

  • 1. Exposure to organic solvents and multiple sclerosis.
    Landtblom AM
    Neurology; 1997 Aug; 49(2 Suppl 2):S70-4. PubMed ID: 9270695
    [No Abstract]   [Full Text] [Related]  

  • 2. Organic solvents and multiple sclerosis: a synthesis of the current evidence.
    Landtblom AM; Flodin U; Söderfeldt B; Wolfson C; Axelson O
    Epidemiology; 1996 Jul; 7(4):429-33. PubMed ID: 8793371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis and organic solvents.
    Mortensen JT; Brønnum-Hansen H; Rasmussen K
    Epidemiology; 1998 Mar; 9(2):168-171. PubMed ID: 9504285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic solvents and the risk of multiple sclerosis.
    Weatherby SJ
    Epidemiology; 2003 Jul; 14(4):506; author reply 507. PubMed ID: 12843780
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of multiple sclerosis triggered by organic solvents.
    Reis J; Dietemann JL; Warter JM; Poser CM
    Neurol Sci; 2001 Apr; 22(2):155-8. PubMed ID: 11603618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic solvents and multiple sclerosis: a case-control study.
    Grønning M; Albrektsen G; Kvåle G; Moen B; Aarli JA; Nyland H
    Acta Neurol Scand; 1993 Oct; 88(4):247-50. PubMed ID: 8256566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic solvents and exacerbation of M.S.
    Poulton TJ
    Aviat Space Environ Med; 1997 Dec; 68(12):1160. PubMed ID: 9408573
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems.
    Landtblom AM; Wastenson M; Ahmadi A; Söderkvist P
    Neurol Sci; 2003 Nov; 24(4):248-51. PubMed ID: 14658041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficult to prove the connection between exposure-occupational injury. A painter was denied compensation because of incorrect conclusions].
    Bring J
    Lakartidningen; 1998 Sep; 95(39):4223-4. PubMed ID: 9785769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Exposure to solvents and MS: complex pathogenesis causes problems when it comes to the right of occupational injury compensation].
    Landtblom AM
    Lakartidningen; 1999 Mar; 96(12):1471-3. PubMed ID: 10222709
    [No Abstract]   [Full Text] [Related]  

  • 11. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions.
    Napier MD; Poole C; Satten GA; Ashley-Koch A; Marrie RA; Williamson DM
    Arch Environ Occup Health; 2016; 71(1):26-34. PubMed ID: 25137520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another possible precipitating factor in multiple sclerosis: the exposure to organic solvents.
    Amaducci L; Arfaioli C; Inzitari D; Martinetti MG
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):613-7. PubMed ID: 629852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature.
    Brasington RD; Thorpe-Swenson AJ
    Arthritis Rheum; 1991 May; 34(5):631-3. PubMed ID: 2025315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and multiple sclerosis.
    Schiffer RB
    Neurology; 1994 Oct; 44(10):1987-8. PubMed ID: 7936271
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis prevalence and possible lead exposure.
    Turabelidze G; Schootman M; Zhu BP; Malone JL; Horowitz S; Weidinger J; Williamson D; Simoes E
    J Neurol Sci; 2008 Jun; 269(1-2):158-62. PubMed ID: 18282582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and occupational exposure to chemicals: a co-twin control study of a nationwide series of twins.
    Juntunen J; Kinnunen E; Antti-Poika M; Koskenvuo M
    Br J Ind Med; 1989 Jun; 46(6):417-9. PubMed ID: 2818977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypointensity in T2-weighted images of the basal ganglia in solvent-exposed patients with multiple sclerosis: clinical, MRI and CSF characteristics.
    Landtblom AM; Thuomas KA; Sjödqvist L; Flodin U; Nyland FH; Söderfeldt B
    Neurol Sci; 2003 Apr; 24(1):2-9. PubMed ID: 12754650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of multiple sclerosis in communities concerned about environmental exposures.
    Williamson DM
    J Womens Health (Larchmt); 2006 Sep; 15(7):810-4. PubMed ID: 16999635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to organic solvents--II. An exposure epidemiology study.
    Olsen E; Seedorff L
    Ann Occup Hyg; 1990 Aug; 34(4):379-89. PubMed ID: 2240992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies based on the Danish Multiple Sclerosis Registry.
    Koch-Henriksen N; Stenager E; Brønnum-Hansen H
    Scand J Public Health; 2011 Jul; 39(7 Suppl):180-4. PubMed ID: 21775380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.